REG - Syncona Limited - Result of AGM

SynconaAnnouncement

30/07/2019 12:00

RNS Number : 2150H
Syncona Limited
30 July 2019
 


Syncona Limited
Result of Annual General Meeting 
30 July 2019
At the Annual General Meeting of the Company held today, all Resolutions as set out in the 'Notice of the 2019 Annual General Meeting' dated 27 June 2019 sent to shareholders of the Company (the "Notice") were duly passed.
Resolutions 1 to 13 were proposed as ordinary resolutions. Resolution 14 was proposed as a Special Resolution and Resolution 15 was proposed as an Extraordinary Resolution.
Details of the proxy voting results, which should be read alongside the Notice, are noted below:



No


Resolution


For


Against


Abstain


Discretion




1


Receive and consider the Annual Audited Financial Statements of the Company for the year ended 31 March 2019, together with the Reports of the Directors and Auditors thereon


435,492,895


247,369


0


25,774




2


Re-appointment Deloitte LLP (Guernsey Branch) as Auditors


435,511,635


24,433


214,970


15,000




3


Authorise the Directors to determine the remuneration of the Auditors


435,733,447


4,076


2,742


25,774




4


Re-elect Jeremy Tigue as a Director


421,376,075


12,076,117


2,288,072


25,774




5


Elect Melanie Gee as a Director


435,735,679


0


4,586


25,774




6


Re-elect Thomas Henderson as a Director


435,554,836


183,585


1,844


25,774




7


Re-elect Rob Hutchinson as a Director


435,726,044


9,635


4,586


25,774




8


Re-elect Nigel Keen as a Director


435,304,724


430,954


4,586


25,774




9


Re-elect Nick Moss as a Director


435,734,955


724


4,586


25,774




10


Re-elect Gian Piero Reverberi as a Director


435,735,679


0


4,586


25,774




11


Re-elect Ellen Strahlman as a Director


435,735,679


0


4,586


25,774




12


Approve the directors' remuneration report.


435,688,593


49,828


1,844


25,774




13


Authority to allot shares


435,723,353


12,326


4,586


25,774




14


Authorise the Company to purchase its own shares


435,722,250


12,693


2,742


28,354




15


Disapply pre-emption rights


435,720,338


1,987


4,586


39,128



A vote withheld is not a vote in law and has not been counted in the votes for and against a resolution.
In accordance with the Listing Rule 9.6.2, a copy of all the resolutions passed other than resolutions concerning ordinary business have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.
The full text of the resolutions can be found in the Notice, which is available on the Company's website at www.synconaltd.com/investors.
[ENDS]
Enquiries
Syncona Ltd
Siobhan Weaver / Annabel Clay
Tel: +44 (0) 20 3981 7940
FTI Consulting
Brett Pollard / Natalie Garland-Collins
Tel: +44 (0) 20 3727 1000
Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com.
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGWGUPAMUPBGUU